MUSM Women in Medicine Annual Symposium

Estrogen Processing and Breast Cancer Risk Explain why estrogen concentration alone poorly predicts breast cancer risk Describe estrogen metabolic pathway bias (2-OH, 4-OH, 16-OH) Recognize the role of detox capacity, inflammation, and insulin signaling Apply a systems framework for prevention and risk reduction Case-Based Reflections on Risk-Informed Breast Cancer Screening Describe how breast density and family history influence individualized breast cancer risk assessment Discuss when additional imaging beyond routine mammography may be appropriate Apply formal risk assessment tools (e.g., Tyrer-Cuzick) to guide shared decision-making